Airsculpt Technologies Inc (AIRS)vsFresenius Medical Care Corporation (FMS)
AIRS
Airsculpt Technologies Inc
$2.13
-10.50%
HEALTHCARE · Cap: $173.03M
FMS
Fresenius Medical Care Corporation
$22.86
+2.28%
HEALTHCARE · Cap: $12.06B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 12789% more annual revenue ($19.43B vs $150.72M). FMS leads profitability with a 4.8% profit margin vs -7.8%. FMS earns a higher WallStSmart Score of 58/100 (C).
AIRS
Hold38
out of 100
Grade: F
FMS
Buy58
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+34.4%
Fair Value
$3.23
Current Price
$2.13
$1.10 discount
Margin of Safety
+68.6%
Fair Value
$76.58
Current Price
$22.86
$53.72 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 200.0% YoY
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -11.2% — below average capital efficiency
Revenue declined 2.5%
1.4% revenue growth
Grey zone — moderate risk
ROE of 7.5% — below average capital efficiency
4.8% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : AIRS
The strongest argument for AIRS centers on Price/Book, EPS Growth.
Bull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.
Bear Case : AIRS
The primary concerns for AIRS are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : FMS
The primary concerns for FMS are Revenue Growth, Altman Z-Score, Return on Equity. Thin 4.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
AIRS profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.
AIRS carries more volatility with a beta of 2.29 — expect wider price swings.
FMS is growing revenue faster at 1.4% — sustainability is the question.
FMS generates stronger free cash flow (620M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (58/100 vs 38/100). AIRS offers better value entry with a 34.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Airsculpt Technologies Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, specializing in its proprietary AirSculpt® procedure, which sets a new standard for minimally invasive body contouring while prioritizing patient safety and comfort. The company is aggressively expanding its network of licensed practitioners and utilizing innovative technologies to solidify its competitive advantage in the rapidly growing non-invasive cosmetic treatment market. With rising global demand for aesthetic solutions, Airsculpt is well-positioned to capture market share and broaden its service offerings, driving robust growth and long-term value for its investors.
Visit Website →Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?